Vijay Deverakonda

Indian pharmaceutical company Lupin has paid $30 million to settle lawsuits in the US for antitrust violations, despite denying all allegations. The settlement is with insurance company Humana. Lupin’s stock has dropped in the last 5 trading sessions, but its Q3FY26 performance saw a 37% YoY profit growth, thanks to strong US sales.